March 20th 2023
Adam Friedman, MD, FAAD, offers highlights from his session at AAD 2023 on how cutaneous dysbiosis plays a role in some common skin conditions.
January 31st 2020
December 16th 2019
December 11th 2019
Breakthrough therapy designation granted to nemolizumab for pruritusDecember 9th 2019
The United States Food and Drug Administration has granted Galderma’s nemolizumab a Breakthrough Therapy Designation following phase 2 results which suggests the drug is a considerable alleviant for pruritus associated with prurigo nodularis.
Atopic dermatitis patients’ access to care varies across USNovember 20th 2019
For patients with atopic dermatitis, access to dermatology care appears to be best in the West and poorest in the Midwest, shows a recent study looking at disparities in access to services across the United States.
Differences underlie pathology, indicating efficacy of atopic dermatitis treatments may varyOctober 10th 2019
Atopic dermatitis presents differently depending on whether the patient is an adult or child. This means that different treatments may be more effective in an adult than children and vice versa.
Can antibacterial fabrics help manage atopic dermatitis?May 24th 2019
Clothing is a secondary skin and can influence the severity of skin conditions such as atopic dermatitis. But the antibacterial effectiveness of specialized clothing used to reduce disease symptoms varies considerably. Researchers recently decided to put these fabrics to the test - here's what they found.
A game-changer for children with atopic dermatitisApril 26th 2019
“Pretty much, I couldn’t go about my normal life,” says Benjamin Sun about a life-altering eczema flare up at age 9, which left him out of school and bedridden for weeks. Until now, children like Sun didn’t have an effective, safe option for long-term disease control. Read how dupilumab changed his quality of life, and what it can do for your pediatric patients with uncontrolled moderate to severe atopic dermatitis.
Shared decision-making for treating atopic dermatitisOctober 15th 2018
Atopic dermatitis patients are likely more willing to adhere to treatment and achieve better outcomes when there is shared decision-making between the clinician and patient, according to an article in press in the Annals of Allergy, Asthma and Immunology.